Hypertension Clinical Trial
Official title:
Effect of a Beetroot-based Nutritional Gel on Vascular Function and Forearm Muscle Oxygenation Responses in the Elderly at Cardiometabolic Risk
Aging has been associated with reduced bioavailability of nitric oxide (NO) and endothelial dysfunction. Beetroot consumption, a nitrate-rich food, has been associated with increased NO bioconversion, which may promote beneficial effects on vascular health. The present study evaluated the effects of a beetroot-based nutritional gel (BG) on vascular function, arterial stiffness and blood pressure in the elderly at cardiometabolic risk. Twenty elderly individuals were submitted to BG and nitrate-depleted gel (PLA) interventions. Brachial flow-mediated dilation (FMD), blood flow velocity (BFV), peak wave velocity (PWVβ), augmentation index (AI), stiffness parameter (β), pressure-strain elasticity modulus (Ep), arterial compliance (AC), muscle oxygenation and function were measured 90 min after interventions. Urinary nitrate, nitrite, systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were measured at baseline, 90 min and 150 min after interventions.
Status | Completed |
Enrollment | 25 |
Est. completion date | January 2016 |
Est. primary completion date | November 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 65 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Elderly participants (= 65 years) - Taking between 1 and 3 anti-hypertensive medications for high blood pressure; - Elevated triglycerides = 150 mg/dL; - Reduced HDL-cholesterol < 50 mg/dL for women and < 40 mg/dL for men; - Elevated waist circumference by population definition (male: > 102 cm and female: > 88 cm). Exclusion Criteria: elevated fasting glucose (= 100 mg/dL), smoking, beetroot allergy, unwillingness to avoid beetroot products during the entire study, other chronic diseases (diabetes, liver disease, etc.), or acutely ill. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Universidade Federal do Rio de Janeiro | Rio de Janeiro State Research Supporting Foundation (FAPERJ) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in endothelial function as evaluated by the flow-mediated dilation. | Evaluated 120 min after the nutritional intervention | Yes | |
Primary | Changes in the arterial stiffness as evaluated by the peak wave velocity. | Evaluated 120 min after the nutritional intervention | Yes | |
Primary | Changes in the clinical blood pressure | Evaluated before, 120 min and 180 min after the nutritional intervention | Yes | |
Primary | Changes in the muscle oxygenation as evaluated by the levels of oxygenated and deoxygenated hemoglobin | Evaluated 150 min after the nutritional intervention | Yes | |
Primary | Changes in the muscle function as evaluated by the maximal voluntary contraction of the forearm muscle | Evaluated before and 180 min after the nutritional intervention | Yes | |
Primary | Changes in endothelial function as evaluated by blood flow velocity | Evaluated 120 min after the nutritional intervention | Yes | |
Primary | Changes in endothelial function as evaluated by reactive hyperemia. | Evaluated 120 min after the nutritional intervention | Yes | |
Primary | Changes in the arterial stiffness as evaluated by augmentation index | Evaluated 120 min after the nutritional intervention | Yes | |
Primary | Changes in the arterial stiffness as evaluated by the stiffness parameter | Evaluated 120 min after the nutritional intervention | Yes | |
Primary | Changes in the arterial stiffness as evaluated by the pressure-strain elasticity modulus | Evaluated 120 min after the nutritional intervention | Yes | |
Primary | Changes in the arterial stiffness as evaluated by the arterial compliance. | Evaluated 120 min after the nutritional intervention | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |